4-aminopyridine has been researched along with carboplatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kishimoto, R; Matsushima, M; Motomura, M; Nakadate, M; Sasaki, H; Shiraishi, H; Tsuji, S; Yabe, I; Yaguchi, H | 1 |
Ejaz, SA; Hassan, S; Iqbal, J; Lecka, J; Saeed, A; Sévigny, J; Shabir, G; Shehzad, M; Ullah Khan, S | 1 |
2 other study(ies) available for 4-aminopyridine and carboplatin
Article | Year |
---|---|
[Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Topics: 4-Aminopyridine; Amifampridine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Male; Middle Aged; Pyridostigmine Bromide; Treatment Outcome | 2007 |
4-Aminopyridine based amide derivatives as dual inhibitors of tissue non-specific alkaline phosphatase and ecto-5'-nucleotidase with potential anticancer activity.
Topics: 4-Aminopyridine; 5'-Nucleotidase; Alkaline Phosphatase; Aminopyridines; Antineoplastic Agents; Apoptosis; Benzamides; Carboplatin; Catalytic Domain; Cell Cycle Checkpoints; Cell Line, Tumor; DNA; Enzyme Inhibitors; Humans; Hydrogen Bonding; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |